Peter Heath, a former vice president and chief financial officer at Medtox Scientific, Inc., is the new CFO at Norak Biosciences.

According to Norak, heath has more than 20 years experience at both publicly and privately held life science companies. At Medtox, he oversaw the acquisition of three companies and the placing of $48 million in secondary equity and $11 million in debt financing.

Heath earned his undergraduate degree in economics from the University of Delaware and a masters in business from Wake Forest.